-
CPHI China 2026 Exhibition Site | Sinopeg W4F66, We Are Waiting for You!
June 17,2026.
CPHI China 2026 Kicks Off with a Crowd at Shanghai New International Expo Centre On June 16, the 24th edition of CPhI China officially opened its doors. As a key benchmark for the global pharmaceutica...
View More
-
R&D News | Sinopeg’s Key Excipient for Nucleic Acid Drug Delivery, DSPE-PEG-MAL, Reaches Another Milestone – CDE Filing Completed!
June 8,2026.
Recently, Sinopeg’s LNP lipid excipient product, DSPE-PEG-MAL(NH4+)-2K, has successfully completed pharmaceutical excipient filing with the Center for Drug Evaluation (CDE) of the National Medical Pro...
View More
-
DPPE | Sinopeg
June 5,2026.
I. Basic Information Name: 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine CAS Number: 923-61-5 Appearance: White powder Storage Conditions: Store sealed, protected from light, below -20°C. II. Struc...
View More
-
CbzNH-PEGn-NH₂ | Sinopeg
June 4,2026.
I. Product Overview CbzNH-PEGn-NH₂ is a multifunctional, dual-group heterobifunctional PEG crosslinker. One end of the molecule features a benzyloxycarbonyl (Cbz) protecting group, while the other end...
View More
-
Unlocking in vivo CAR-T therapy with DSPE-PEG-MAL - A chemical bridge to the next generation of cell treatment
May 21,2026.
The revolution of in vivo CAR-T is here. After decades of impressive but logistically challenging ex vivo CAR-T, 2025 marks the turning point-Capstan’s CPTX2309 entered Phase I, and AbbVie acquired Ca...
View More
-
Amino-PEG-Acetic Acid (PEG1-12) | Sinopeg
May 20,2026.
I. Product Overview Amino-PEG-Acetic Acid (Amine-PEG-Acetic Acid) is a well-defined functional PEG reagent with a variable length of 1–12 ethylene glycol units. The molecule contains a reactive amino ...
View More
-
Fmoc-PEGn-COOH (n=1-12) – Multifunctional Cleavable PEG Linker | Sinopeg
May 15,2026.
I. Product Overview Fmoc-PEGn-COOH is a multifunctional heterobifunctional crosslinker that integrates a protecting group, a hydrophilic spacer arm, and a reactive terminal. The molecule features an F...
View More
-
Accelerate Radiopharmaceutical R&D with a Complete Precursor Building Block Platform
May 11,2026.
At Sinopeg, we’re dedicated to empowering radiopharmaceutical innovators with a comprehensive library of precursor building blocks covering all three core modules of radiopharmaceutical molecules: Lig...
View More
-
Unlocking the Next Generation of Precision Drug Delivery with DMG-pSar25
May 9,2026.
In the rapidly evolving world of nanomedicine, “precision drug delivery” is no longer just a vision—it’s becoming reality. And at the heart of this breakthrough lie high-performance nanocarriers. &nbs...
View More